Clinical Trial Update: Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of cladribine, cytarabine, and idarubicin in patients with relapsed acute myeloid leukemia is reported. The current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Cladribine (cladribine)
• Idarubicin (idarubicin)

Snippet

Sponsor: University Hospital, Bonn | Conditions: Leukemia, Myelocytic, Acute | Phase 2 | Status: UNKNOWN